2010 Scrip 100 - Is Anvisa a friend of innovators?
This article was originally published in Scrip
Executive Summary
A decade since its formation Anvisa, Brazil's medicines regulator, has shaken up the country's framework for ensuring drug quality. Yet the agency's approaches to drug pricing and registration have left some multinationals wanting, reports Sita Shah.